XML 34 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Previously Reported [Member]
Common Stock
Common Stock
Previously Reported [Member]
Common Stock
Pre-Funded Warrants
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance, beginning (in shares) at Dec. 31, 2020     8,439,259          
Balance, beginning at Dec. 31, 2020 $ 191,216         $ 524,022 $ (332,806)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued upon exercises of stock options (in shares)   24,985 24,986          
Shares issued upon exercises of stock options 411         411    
Shares issued upon vesting of restricted stock units (in shares)     16,900          
Issuance of shares under Employee Stock Purchase Plan (in shares)     10,349          
Issuance of shares under Employee Stock Purchase Plan 372         372    
Stock-based compensation 11,557         11,557    
Net loss (60,692)           (60,692)  
Balance, ending (in shares) at Dec. 31, 2021     8,491,493 8,491,494        
Balance, ending at Dec. 31, 2021 142,864         536,362 (393,498)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued upon exercises of stock options (in shares)     7,300          
Shares issued upon exercises of stock options 134         134    
Stock-based compensation 2,446         2,446    
Net loss (15,351)           (15,351)  
Balance, ending (in shares) at Mar. 31, 2022     8,498,794          
Balance, ending at Mar. 31, 2022 130,093         538,942 (408,849) $ 0
Balance, beginning (in shares) at Dec. 31, 2021     8,491,493 8,491,494        
Balance, beginning at Dec. 31, 2021 142,864         536,362 (393,498)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Unrealized gain (loss) on available-for-sale securities (72)              
Net loss (31,039)              
Balance, ending (in shares) at Jun. 30, 2022     8,515,970          
Balance, ending at Jun. 30, 2022 116,708         541,317 (424,537) (72)
Balance, beginning (in shares) at Dec. 31, 2021     8,491,493 8,491,494        
Balance, beginning at Dec. 31, 2021 $ 142,864         536,362 (393,498)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued upon exercises of stock options (in shares) 7,300   7,300          
Shares issued upon exercises of stock options $ 134         134    
Shares issued upon vesting of restricted stock units (in shares)     4,950          
Issuance of shares under Employee Stock Purchase Plan (in shares)     25,925          
Issuance of shares under Employee Stock Purchase Plan 82         82    
Unrealized gain (loss) on available-for-sale securities (21)             (21)
Stock-based compensation 8,829         8,829    
Net loss (57,557)           (57,557)  
Balance, ending (in shares) at Dec. 31, 2022   8,529,668 8,529,669          
Balance, ending at Dec. 31, 2022 94,331         545,407 (451,055) (21)
Balance, beginning (in shares) at Mar. 31, 2022     8,498,794          
Balance, beginning at Mar. 31, 2022 130,093         538,942 (408,849) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued upon vesting of restricted stock units (in shares)     2,000          
Issuance of shares under Employee Stock Purchase Plan (in shares)     15,176          
Issuance of shares under Employee Stock Purchase Plan 63         63    
Unrealized gain (loss) on available-for-sale securities (72)             (72)
Stock-based compensation 2,312         2,312    
Net loss (15,688)           (15,688)  
Balance, ending (in shares) at Jun. 30, 2022     8,515,970          
Balance, ending at Jun. 30, 2022 116,708         541,317 (424,537) (72)
Balance, beginning (in shares) at Dec. 31, 2022   8,529,668 8,529,669          
Balance, beginning at Dec. 31, 2022 94,331         545,407 (451,055) (21)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued upon vesting of restricted stock units (in shares)     34,000          
Unrealized gain (loss) on available-for-sale securities 39             39
Stock-based compensation 1,191         1,191    
Net loss (14,204)           (14,204)  
Balance, ending (in shares) at Mar. 31, 2023     8,563,669          
Balance, ending at Mar. 31, 2023 81,357         546,598 (465,259) 18
Balance, beginning (in shares) at Dec. 31, 2022   8,529,668 8,529,669          
Balance, beginning at Dec. 31, 2022 $ 94,331         545,407 (451,055) (21)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued upon exercises of stock options (in shares) 0   7,300          
Unrealized gain (loss) on available-for-sale securities $ 8              
Net loss (16,289)              
Balance, ending (in shares) at Jun. 30, 2023     8,804,285          
Balance, ending at Jun. 30, 2023 79,576         546,933 (467,344) (13)
Balance, beginning (in shares) at Mar. 31, 2023     8,563,669          
Balance, beginning at Mar. 31, 2023 81,357         546,598 (465,259) 18
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued upon vesting of restricted stock units (in shares)     2,000          
Shares issued upon the exercise of pre-funded warrants (in shares)         236,000      
Issuance of shares under Employee Stock Purchase Plan (in shares)     2,616          
Issuance of shares under Employee Stock Purchase Plan 4         4    
Unrealized gain (loss) on available-for-sale securities (31)             (31)
Stock-based compensation 331         331    
Net loss (2,085)           (2,085)  
Balance, ending (in shares) at Jun. 30, 2023     8,804,285          
Balance, ending at Jun. 30, 2023 $ 79,576         $ 546,933 $ (467,344) $ (13)